V. Carreño

M. Diago, V. Carreño, J. Quiroga, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.

V. Carreño, C. Caramelo, S. Navas, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.

V. Carreño, S. Navas, J. Quiroga, 1996, The Journal of infectious diseases.

Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity, and liver disease outcome

Changcai Wang, V. Carreño, J. van Binsbergen, 1995, Hepatology.

α- and γ-interferon versus α-interferon alone in chronic hepatitis B

A. Moreno, V. Carreño, F. Galiana, 1993 .

Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study.

A. Moreno, V. Carreño, F. Galiana, 1993, Journal of hepatology.

Treatment of children with chronic hepatitis C with recombinant interferon‐α: A pilot study

V. Carreño, M. J. Ruá, M. D. García-Novo, 1992, Hepatology.

Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver

J. Bartolomé, A. Moreno, V. Carreño, 1992, Journal of medical virology.

Prospective, randomized controlled trial of interferon‐α in children with chronic hepatitis B

A. Moreno, V. Carreño, M. J. Ruá, 1991, Hepatology.

High doses of recombinant α‐interferon or γ‐interferon for chronic hepatitis C: A randomized, controlled trial

A. Moreno, V. Carreño, F. Sáez‐royuela, 1991 .

Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control group

A. Moreno, V. Carreño, I. Castillo, 1990 .

Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.

A. Moreno, V. Carreño, J. Quiroga, 1989, Journal of hepatology.

Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.

J. Bartolomé, V. Carreño, C. Bas, 2008, Liver.

Impact of Isolated Hepatitis C Virus (HCV) Core-Specific Antibody Detection and Viral RNA Amplification among HCV-Seronegative Dialysis Patients at Risk for Infection

J. Bartolomé, V. Carreño, M. Arenas, 2014, Journal of Clinical Microbiology.

Serum levels of anti‐NS4a and anti‐NS5a predict treatment response of patients with chronic hepatitis C

H. Van Vlierberghe, O. Weiland, G. Leroux-Roels, 2007, Journal of medical virology.

In situ detection of hepatitis C virus RNA in salivary glands.

J. Bartolomé, V. Carreño, F. Manzarbeitia, 2001, The American journal of pathology.

Association of HLA-DR genes with mild idiopathic adulthood biliary ductopenia

V. Carreño, J. Quiroga, M. Pardo, 2001, American Journal of Gastroenterology.

Comparative study between occult hepatitis C virus infection and chronic hepatitis C

V. Carreño, I. Castillo, M. Pardo, 2007, Journal of viral hepatitis.

Presence of HCV‐RNA after ultracentrifugation of serum samples during the follow‐up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection

V. Carreño, G. Barril, I. Castillo, 2009, Alimentary pharmacology & therapeutics.

Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff.

J. Bartolomé, V. Carreño, C. Caramelo, 1997, Journal of the American Society of Nephrology : JASN.

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.

A. Moreno, V. Carreño, F. Sáez‐royuela, 1991, Hepatology.

Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter

J. Bartolomé, V. Carreño, J. Bartolomé, 1999, Hepatology.

Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti–hepatitis C virus–positive patients with and without oral lichen planus

J. Bartolomé, V. Carreño, F. Manzarbeitia, 2000, Hepatology.

Sequence variation of hepatitis B virus precore‐core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment

J. Bartolomé, V. Carreño, M. Cabrerizo, 1999, Journal of medical virology.

Review article: management of chronic hepatitis C in patients with contraindications to anti‐viral therapy

V. Carreño, 2014, Alimentary pharmacology & therapeutics.

Influence of hepatitis delta virus replication in the presence of hepatitis B virus DNA in peripheral blood mononuclear cells

J. Bartolomé, V. Carreño, G. Moraleda, 1990, Hepatology.

Hepatitis B virus DNA patterns in the liver of children with chronic hepatitis B

J. Bartolomé, V. Carreño, G. Moraleda, 1990, Journal of medical virology.

Analysis of hepatitis B virus DNA, liver disease and influence of antibody to hepatitis C virus in anti-HBe chronic carriers.

V. Carreño, G. Moraleda, I. Castillo, 2008, Liver.

Hepatitis B virus DNA in liver and peripheral blood mononuclear cells during reduction in virus replication.

V. Carreño, G. Moraleda, J. Bartolomé, 1990, Gastroenterology.

Presence of HBV-DNA in peripheral blood mononuclear cells from anti-HIV symptomless carriers.

V. Carreño, G. Moraleda, I. Castillo, 1990, Journal of hepatology.

Assessment of hepatitis B virus DNA levels in chronic HBsAg carriers with or without hepatitis delta virus superinfection.

V. Carreño, J. Quiroga, C. Bas, 1988, Journal of hepatology.

Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection

J. Bartolomé, V. Carreño, I. Castillo, 2007, Journal of medical virology.

TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells.

J. Bartolomé, V. Carreño, S. de Lucas, 2002, Virology.

In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients.

V. Carreño, M. Rico, S. Navas, 1999, Antiviral research.

Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-κB activation

J. Bartolomé, V. Carreño, S. D. Lucas, 2003 .

Hepatitis C virus replicates in sweat glands and is released into sweat in patients with chronic hepatitis C

J. Bartolomé, V. Carreño, P. Lázaro, 2002, Journal of medical virology.

Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C.

J. Bartolomé, V. Carreño, P. Lázaro, 2002, The Journal of investigative dermatology.

Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands.

V. Carreño, A. Madejón, I. Castillo, 2000, Journal of hepatology.

Fluorescent “in situ” hybridization of hepatitis C virus RNA in peripheral blood mononuclear cells from patients with chronic hepatitis C

J. Bartolomé, V. Carreño, S. Navas, 2000, Journal of medical virology.

Sequence of non-structural regions 3 and 5 of hepatitis C virus genomes from Spanish patients: existence of a predominant variant related to type 1b.

J. Bartolomé, V. Carreño, I. Castillo, 1995, The Journal of general virology.

Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells.

V. Carreño, S. Navas, I. Castillo, 1993, Journal of hepatology.

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

P. Andersen, H. Thomas, G. Gerken, 1994, Journal of hepatology.

Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study.

V. Gómez-García de Soria, V. Carreño, J. Bartolomé, 1997, Blood.

Decreased nitric oxide production in chronic viral hepatitis B and C

J. Bartolomé, V. Carreño, A. López-Farré, 1997, Journal of medical virology.

Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony‐stimulating factor plus recombinant interferon‐alpha

V. Carreño, S. Navas, I. Castillo, 1995, Journal of medical virology.

Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay

V. Carreño, S. Navas, I. Castillo, 1997, Journal of clinical microbiology.

Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C

J. Bartolomé, V. Carreño, A. Madejón, 1995, Journal of medical virology.

Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C.

V. Carreño, I. Castillo, J. Quiroga, 1994, Clinical and diagnostic laboratory immunology.

Virological and biochemical long‐term follow‐up of patients with chronic hepatitis c treated with interferon

J. Bartolomé, V. Carreño, S. Navas, 1994, Hepatology.

Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion.

V. Carreño, E. Marriott, S. Navas, 1994, Journal of hepatology.

An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C.

V. Carreño, J. Quiroga, L. Tapia, 1993, Journal of hepatology.

Liver biopsy and the etiologic diagnosis of chronic hepatitis.

A. Moreno, V. Carreño, C. J. Martinez, 1993, Journal of hepatology.

Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon‐alpha

V. Carreño, I. Castillo, J. Quiroga, 1992, Journal of medical virology.

A pilot study of recombinant interleukin‐2 for treatment of chronic hepatitis C

V. Carreño, I. Castillo, A. Fernandez-Flores, 1997, Hepatology.

Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.

V. Carreño, C. Caramelo, S. Navas, 1994, Nephron.

Biological properties of interleukin‐12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infection

V. Carreño, J. Quiroga, 1997, Journal of viral hepatitis.

Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation.

J. Bartolomé, V. Carreño, S. de Lucas, 2003, Antiviral research.

Prophyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study

V. Carreño, E. Marriott, S. Navas, 1995, Hepatology.

Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors.

V. Carreño, R. Enríquez de Salamanca, J. M. Cortés, 1985, Journal of hepatology.

Concentrated ascitic fluid reinfusion in cirrhotic patients: a simplified method.

V. Carreño, C. Caramelo, E. Marriott, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B

S. Ramón y. Cajal, V. Carreño, M. Cabrerizo, 1999, Hepatology.

Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients.

V. Carreño, S. Navas, J. Quiroga, 1998, Cytokine.

Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection

J. Bartolomé, V. Carreño, I. Castillo, 2003, Journal of medical virology.

In vitro infection of human peripheral blood mononuclear cells by a defective hepatitis B virus with a deletion in the PreS1 region of the viral genome

V. Carreño, M. Cabrerizo, J. Bartolomé, 2002, Journal of viral hepatitis.

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen–negative cases

J. Bartolomé, V. Carreño, C. Caramelo, 2000 .

Epidemiological and clinical implications in Kidney Transplantation of occult Hepatitis C virus infection

R. Selgas, J. Bartolomé, V. Carreño, 2019, Archives of Clinical Nephrology.

Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease.

V. Carreño, C. Caramelo, M. Rico, 2000, Cytokine.

Undiagnosed hepatitis C virus infection in hemodialysis patients: value of HCV RNA and liver enzyme levels.

V. Carreño, C. Caramelo, E. Marriott, 1996, Kidney international.

Identification of different degrees of hepatitis B virus (HBV) replication by serological (HBV-DNAp, HBcAg and HBV-DNA) and histological (HBcAg) methods.

V. Carreño, J. Quiroga, J. Bartolomé, 2008, Liver.

Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection.

J. Bartolomé, V. Carreño, J. Quiroga, 1987, Journal of hepatology.

Interleukin‐28B polymorphisms and interferon gamma inducible protein‐10 serum levels in seronegative occult hepatitis C virus infection

J. Bartolomé, V. Carreño, I. Castillo, 2016, Journal of medical virology.

Seronegative occult hepatitis C virus infection: clinical implications.

V. Carreño, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis C virus infection in the family setting of patients with occult hepatitis C

J. Bartolomé, V. Carreño, G. Barril, 2009, Journal of medical virology.

Hepatitis C virus replication in patients with occult hepatitis C virus infection

J. Bartolomé, V. Carreño, I. Castillo, 2009, Hepatology.

Current therapy of chronic hepatitis B.

J. Bartolomé, V. Carreño, M. Pardo, 2007, Archives of medical research.

Detection of serum inhibitory factor for lymphocyte stimulation in chronic viral hepatitis: relationship with the replication level.

V. Carreño, I. Castillo, J. Quiroga, 2008, Liver.

Detection of human immunodeficiency virus type 1 RNA by in situ hybridization in oral mucosa epithelial cells from anti‐HIV‐1 positive patients

J. Bartolomé, V. Carreño, F. Manzarbeitia, 2005, Journal of medical virology.

Risks and Benefits of Interferon-α in the Treatment of Hepatitis

V. Carreño, E. Marriott, J. Quiroga, 1995 .

Receptors for polymerized human serum albumin in plasma derived hepatitis B vaccines.

V. Carreño, J. Porres, I. Mora, 1987, Vaccine.

Hemagglutination and immunofluorescence studies on polymerized human serum albumin binding activity in chronic hepatitis B virus infection

V. Carreño, J. Porres, I. Mora, 1986, Hepatology.

Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children.

M. Manns, V. Carreño, M. J. Ruá, 1991, Journal of hepatology.

Structural characterization of the 5' untranslated RNA of hepatitis C virus by vibrational spectroscopy.

Pedro Carmona, J. Bartolomé, P. Carmona, 2006, Biophysical chemistry.

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B.

P. Marcellin, S. Zeuzem, M. Diago, 2000, Journal of hepatology.

Factors predictive of response to interferon therapy in children with chronic hepatitis B.

J. Bartolomé, V. Carreño, R. Lopez, 1995, Journal of hepatology.

A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.

J. Bartolomé, A. Moreno, V. Carreño, 1990, Digestion.

Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.

S. Ramón y. Cajal, A. Moreno, V. Carreño, 1988, Hepato-gastroenterology.

A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.

S. Ramón y. Cajal, V. Carreño, J. Quiroga, 1987, Antiviral research.

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy.

J. Bartolomé, V. Carreño, I. Castillo, 1992, Journal of hepatology.

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen–negative cases

J. Bartolomé, V. Carreño, C. Caramelo, 2000, Hepatology.

Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon‐alpha treatment

J. Bartolomé, V. Carreño, H. Oliva, 1997, Journal of medical virology.

Efficacy of prolonged interferon‐alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy

V. Carreño, J. Bartolomé, J. M. López-Alcorocho, 1997, Journal of viral hepatitis.

Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-alpha.

V. Carreño, M. Rico, J. Quiroga, 2001, Antiviral research.

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Can Coinfect the Same Hepatocyte in the Liver of Patients with Chronic HCV and Occult HBV Infection

J. Bartolomé, V. Carreño, I. Castillo, 2005, Journal of Virology.

Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins.

V. Carreño, J. Quiroga, Mario Fernández, 2003, The Journal of general virology.

Pilot study of recombinant human granulocyte‐macrophage colony–stimulating factor in the treatment of chronic hepatitis B

J. Bartolomé, V. Carreño, G. Moraleda, 1993, Hepatology.

Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.

A. Moreno, V. Carreño, M. J. Ruá, 1992, Pediatrics.

Long-term effect of interferon therapy in chronic hepatitis B.

V. Carreño, I. Castillo, J. Bartolomé, 1994, Journal of hepatology.

Changes in anti-idiotype antibodies against anti-HBs during recombinant interferon treatment of chronic hepatitis B.

V. Carreño, J. Quiroga, J. Porres, 1990, Journal of interferon research.

Double‐blind, randomized controlled trial of interleukin‐2 treatment of chronic hepatitis B

G. Fattovich, A. Alberti, G. Giustina, 1998, Journal of medical virology.

Elevation of 2',5'-oligoadenylate synthetase activity and HLA-I associated beta 2-microglobulin in response to recombinant interferon-gamma administration in chronic HBeAg-positive hepatitis.

V. Carreño, J. Quiroga, J. Porres, 1988, Journal of interferon research.

COMBINATION OF RECOMBINANT INTERFERONS ALPHA AND GAMMA IN TREATMENT OF CHRONIC HEPATITIS B

V. Carreño, I. Mora, 1987, The Lancet.

Treatment of chronic hepatitis B with recombinant interferon alpha versus recombinant interferon alpha plus levamisole.

V. Carreño, G. Moraleda, I. Castillo, 1993, Journal of hepatology.

Serological and histological follow up of chronic hepatitis B infection.

J. Bartolomé, V. Carreño, H. Oliva, 1989, Archives of disease in childhood.

Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.

J. Bartolomé, V. Carreño, I. Castillo, 1997, Pediatrics.

Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody–positive patients

V. Carreño, F. Manzarbeitia, J. Quiroga, 2000, Hepatology.

Present treatment expectations and risks of chronic hepatitis C.

V. Carreño, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis B Virus and Hepatitis C Virus: Molecular Biology and Diagnosis

J. Bartolomé, V. Carreño, I. Castillo, 2006 .

Lack of efficacy of inosine pranobex in the treatment of chronic hepatitis C.

V. Carreño, M. Pardo, 1994, Journal of hepatology.

Analysis of the Hepatitis B virus precore and ORF‐X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels

J. Bartolomé, V. Carreño, M. Cabrerizo, 1998, Journal of medical virology.

Detection of hepatitis GB virus type C RNA in serum and liver from children with chronic viral hepatitis B and C

J. Bartolomé, V. Carreño, E. R. García-Trevijano, 1997, Hepatology.

Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection

V. Carreño, J. Quiroga, M. Pardo, 1997, Journal of medical virology.

Distribution of the Predominant Hepatitis B Virus Precore Variants in Hepatitis B e Antigen-Positive Children and Their Effect on Treatment Response

J. Bartolomé, V. Carreño, M. Cabrerizo, 1996, Pediatric Research.

Analysis of hepatitis B virus precore variants in hepatitis B e antibody‐positive patients treated with prednisone plus interferon

V. Carreño, M. Cabrerizo, J. Bartolomé, 1995, Journal of viral hepatitis.

Detection of HBeAg/anti-HBe immune complexes in the reactivation of hepatitis B virus replication among anti-HBe chronic carriers.

V. Carreño, I. Castillo, J. Quiroga, 2008, Liver.

IgM antibody to hepatitis C virus in acute and chronic hepatitis C

J. Bartolomé, V. Carreño, J. Quiroga, 1991, Hepatology.

Ribozymes: structure, characteristics and use as potential antiviral agents.

V. Carreño, A. Madejón, J. Bartolomé, 1995, Journal of hepatology.

Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis C.

M. Diago, V. Carreño, J. Such, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.

D. Subirá, S. Castañón, V. Carreño, 2001, Hepatology.

Alpha-interferon for chronic hepatitis B infection: increased efficacy of prolonged treatment

G. Gerken, H. Janssen, V. Carreño, 1998 .

Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B.

A. Moreno, V. Carreño, M. J. Ruá, 1991, Hepatology.

Interleukin-12 in the treatment of chronic hepatitis B and C.

S. Zeuzem, V. Carreño, 2001, Antiviral research.

High prevalence of occult hepatitis C virus infection in patients with chronic hepatitis B virus infection.

J. Bartolomé, V. Carreño, I. Castillo, 2013, Journal of medical microbiology.

New perspectives in occult hepatitis C virus infection.

J. Bartolomé, V. Carreño, I. Castillo, 2012, World journal of gastroenterology.

Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.

J. Jimenez-Heffernan, J. Bartolomé, V. Carreño, 2004, The Journal of infectious diseases.

Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis

J. Bartolomé, V. Carreño, E. Rodríguez-Iñigo, 1998, Hepatology.

Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon.

V. Carreño, J. Bartolomé, J. Porres, 1989, Journal of hepatology.

In vitro inhibition of the hepatitis delta virus replication mediated by interferon and trans-ribozyme or antisense probes.

V. Carreño, A. Madejón, J. Bartolomé, 1998, Journal of hepatology.

Significance of low HDV replication levels during the natural history of HDV infection. Long-term follow-up.

V. Carreño, A. Madejón, I. Castillo, 1993, Journal of hepatology.

Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection.

A. Moreno, V. Carreño, M. Melero, 1990, Journal of hepatology.

Existence of Distinct GB Virus C/Hepatitis G Virus Variants with Different Tropism

J. Bartolomé, V. Carreño, M. Martín, 2000, Journal of Virology.

, Javier Virus Variants with Different Tropism Existence of Distinct GB Virus C / Hepatitis G

J. Bartolomé, V. Carreño, M. Martín, 2000 .

Antiviral effect of recombinant gamma interferon in chronic hepatitis B virus infection: a pilot study.

J. Bartolomé, V. Carreño, J. Ordi, 1988, Hepato-gastroenterology.

ANTI-IFN-α TTTRES DURING INTERFERON THERAPY

V. Carreño, L. Inglada, J. Porres, 1987, The Lancet.

Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.

A. Lok, H. Thomas, G. Dusheiko, 1994, Journal of viral hepatitis.

Detection of proteins encoded by the pre-S region of hepatitis B virus in the sera of HBsAg carriers: relation to viral replication.

V. Carreño, J. Bartolomé, J. Porres, 2008, Liver.

Genetic Diversity and Tissue Compartmentalization of the Hepatitis C Virus Genome in Blood Mononuclear Cells, Liver, and Serum from Chronic Hepatitis C Patients

V. Carreño, S. Navas, I. Castillo, 1998, Journal of Virology.

Liver membrane antibodies in chronic delta hepatitis.

V. Carreño, J. Quiroga, C. Bas, 1987, Digestion.

Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum

J. Bartolomé, V. Carreño, I. Castillo, 2004, Journal of medical virology.

Effect of anti‐viral therapy for occult hepatitis C virus infection

V. Carreño, I. Castillo, M. Pardo, 2006, Alimentary pharmacology & therapeutics.

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

J. Bartolomé, V. Carreño, S. de Lucas, 2005, The Journal of infectious diseases.

Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy

V. Carreño, G. Moraleda, I. Castillo, 1992, Journal of clinical microbiology.

Occult hepatitis C virus infection among hemodialysis patients.

J. Bartolomé, V. Carreño, M. Arenas, 2008, Journal of the American Society of Nephrology : JASN.

Pegylated interferon‐α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers

R. Selgas, V. Carreño, G. Barril, 2004, Alimentary pharmacology & therapeutics.

Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay

V. Carreño, I. Castillo, J. Quiroga, 1996, Journal of medical virology.

Detection of hepatitis delta virus RNA in chronic liver disease.

J. Saldanha, V. Carreño, A. Craxì, 1989, Journal of hepatology.

Radioimmunoassay for detecting hepatitis B core antigen in serum from patients with chronic hepatitis B infection.

V. Carreño, J. Quiroga, J. Porres, 1985, Clinical chemistry.

Sanded nuclei in delta patients.

M. Marazuela, S. Ramón y. Cajal, A. Moreno, 2008, Liver.

Detection of plus and minus HCV RNA in normal liver of anti-HCV-positive patients

V. Carreño, S. Navas, I. Castillo, 1993, The Lancet.

Identification of a novel GB type C virus/hepatitis G virus subtype in patients with hematologic malignancies

V. Carreño, I. Castillo, J. Tomás, 1999, Journal of medical virology.

Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection

G. Colucci, V. Carreño, S. Navas, 1998, Journal of medical virology.

Detection of hepatitis C virus (HCV) core–specific antibody suggests occult HCV infection among blood donors

J. Bartolomé, V. Carreño, A. Avellón, 2016, Transfusion.

Does Occult Hepatitis C Virus Infection Exist?

J. Bartolomé, V. Carreño, I. Castillo, 2008, Journal of Clinical Microbiology.

Prevalence of TT Virus in Serum and Peripheral Mononuclear Cells from a CAPD Population

R. Selgas, J. Bartolomé, V. Carreño, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

HGV in coagulation-factor concentrates

V. Carreño, E. R. García-Trevijano, J. M. López-Alcorocho, 1996, The Lancet.

Role of cytokines in the response to erythropoietin in hemodialysis patients.

V. Carreño, M. Goicoechea, C. Caramelo, 1998, Kidney international.

Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels.

J. Bartolomé, V. Carreño, M. Pardo, 2005, The Journal of molecular diagnostics : JMD.

Genetic diversity and tissue compartmentalization of hepatitis C virus (HCV) genome in blood mononuclear cells, liver and serum from chronic hepatitis C patients

V. Carreño, S. Navas, I. Castillo, 1998 .

Hepatitis C Virus Genotypes in Serum and Liver of Children with Chronic Hepatitis C

J. Bartolomé, V. Carreño, S. Navas, 1995, Pediatric Research.

Ultracentrifugation of Serum Samples Allows Detection of Hepatitis C Virus RNA in Patients with Occult Hepatitis C

J. Bartolomé, V. Carreño, I. Castillo, 2007, Journal of Virology.

Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection

V. Carreño, I. Castillo, M. Pardo, 2005, Gut.

Retreatment of chronic hepatitis C virus infection

V. Carreño, E. Marriott, J. Quiroga, 1994, The Lancet.

Retreatment of chronic hepatitis C with interferon-alpha.

V. Carreño, E. Marriott, J. Quiroga, 1992, The Journal of infectious diseases.

Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection

J. Bartolomé, V. Carreño, Sonia Vidal, 2008, Journal of medical virology.

Subject Index, Vol. 66, 1994

S. Agarwal, A. Ooshima, G. Baldari, 1994 .

Transplantation of allogeneic CD34-selected peripheral stem cells does not prevent transmission of hepatitis C virus from an infected donor

V. Carreño, A. Alegre, J. Bartolomé, 1999, Bone Marrow Transplantation.

Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels

R. Selgas, J. Bartolomé, V. Carreño, 2010, Journal of medical virology.

GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D.

V. Carreño, A. Madejón, M. Pardo, 1997, Gastroenterology.

Occult Hepatitis C Virus Infection in Patients with Diabetic Nephropathy: Epidemiological and Clinical Implications

R. Selgas, J. Bartolomé, V. Carreño, 2016 .

Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.

V. Carreño, E. Marriott, I. Castillo, 1992, Gastroenterology.

Virus‐specific effector CD4+ T‐cell responses in hemodialysis patients with hepatitis C virus infection

R. Selgas, D. Subirá, S. Castañón, 2004, Journal of medical virology.

Occult hepatitis C virus infection: a new form of hepatitis C.

V. Carreño, 2006, World journal of gastroenterology.

Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially

R. Selgas, J. Bartolomé, V. Carreño, 2000, Journal of medical virology.

Phylogenetic Analysis of Hepatitis GB Virus Type C/Hepatitis G Virus in Spanish Patients with Chronic Hepatitis B or C Virus Infection

J. Bartolomé, V. Carreño, M. Cabrerizo, 1999, Intervirology.

Hepatitis GB virus C.

V. Carreño, J. Bartolomé, J. Tomás, 1996, New England Journal of Medicine.

Increase in triglicerides during α-interferon treatment of chronic viral hepatitis

V. Carreño, M. J. Ruá, E. Marriott, 1992 .

Viral RNA Amplification among at Risk HCV-seronegative Dialysis Patients.

J. Bartolomé, V. Carreño, M. Arenas, 2014 .

Diagnosis of occult hepatitis C without the need for a liver biopsy

J. Bartolomé, V. Carreño, G. Barril, 2010, Journal of medical virology.

Serum Immunoglobulin G Antibodies to the GOR Autoepitope Are Present in Patients with Occult Hepatitis C Virus (HCV) Infection despite Lack of HCV-Specific Antibodies

J. Bartolomé, V. Carreño, I. Castillo, 2007, Clinical and Vaccine Immunology.

Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection.

V. Carreño, M. Melero, A. Madejón, 1991, Digestion.

Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha.

V. Carreño, J. Quiroga, M. Pardo, 1994, Digestive diseases and sciences.

Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells.

V. Carreño, S. Navas, J. Quiroga, 1999, Cytokine.

Improved Sensitivity for Cell Mapping of Hepatitis C Virus RNA Sequences and Cellular Surface Antigens in Blood Cells

J. Gosálvez, J. Bartolomé, A. Gosálbez, 2003, Laboratory Investigation.

Long‐term virological follow up of patients with occult hepatitis C virus infection

J. Bartolomé, V. Carreño, G. Barril, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.

J. Bartolomé, V. Carreño, I. Castillo, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Combined Hepatitis C Virus (HCV) Antigen-Antibody Detection Assay Does Not Improve Diagnosis for Seronegative Individuals with Occult HCV Infection

V. Carreño, I. Castillo, J. Quiroga, 2006, Journal of Clinical Microbiology.

The role of genomic and antigenomic HCV‐RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy

V. Carreño, I. Castillo, J. Quiroga, 2007, Alimentary pharmacology & therapeutics.

82 A CONTROLLED TRIAL OF RECOMBINANT IFN-α TREATMENT DURING 3 MONTHS OF CHRONIC HEPATITIS B IN CHILDREN

V. Carreño, J. Porres, I. Mora, 1988, Pediatric Research.

Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk

V. Carreño, U. Hedner, J. Quiroga, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.

J. Bartolomé, V. Carreño, I. Castillo, 2006, The Journal of infectious diseases.

Hepatitis B Virus Infection

Ding‐Shinn Chen, C. Blanpain, V. Carreño, 2007 .